Marcelo Bravo

Marcelo Bravo is the Interim - Chief Commercial Officer at CellRev, a pioneering spinoff from the University of Newcastle that created a scalable adherent cell processing platform. Marcelo is also the Executive Chairman & Founder of Oxford Pharmascience Ltd, a pharmaceutic technology company using proprietary drug delivery technologies. In addition, Marcelo was the Co Founder & Chief Executive Officer of OXvax Ltd, where Marcelo outlined the design of a next-generation cancer vaccine. With a background in R&D at Procter & Gamble and extensive experience in founding and leading various companies, Marcelo has a strong academic background with degrees from the University of Oxford, London Business School, Case Western Reserve University, and The College of Wooster.